Literature DB >> 25410229

Clinical and diagnostic features of small fiber damage in diabetic polyneuropathy.

S Javed1, I N Petropoulos2, M Tavakoli1, R A Malik3.   

Abstract

Small fiber neuropathy represents a significant component of diabetic sensorimotor polyneuropathy (DSPN) which has to date been ignored in most recommendations for the diagnosis of DSPN. Small fibers predominate in the peripheral nerve, serve crucial and highly clinically relevant functions such as pain, and regulate microvascular blood flow, mediating the mechanisms underlying foot ulceration. An increasing number of diagnostic tests have been developed to quantify small fiber damage. Because small fiber damage precedes large fiber damage, diagnostic tests for DSPN show good sensitivity but moderate specificity, because the gold standard which is used to define DSPN is large fiber-weighted. Hence new diagnostic algorithms for DSPN should acknowledge this emerging data and incorporate small fiber evaluation as a key measure in the diagnosis of DSPN, especially early neuropathy.

Entities:  

Keywords:  IENFD; Small fibers; corneal confocal microscopy; quantitative sensory testing; sudomotor dysfunction

Mesh:

Year:  2014        PMID: 25410229     DOI: 10.1016/B978-0-444-53480-4.00019-9

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  7 in total

Review 1.  Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.

Authors:  Saad Javed; Uazman Alam; Rayaz A Malik
Journal:  Rev Diabet Stud       Date:  2015-08-10

2.  Metformin protects from oxaliplatin induced peripheral neuropathy in rats.

Authors:  N W Martinez; A Sánchez; P Diaz; R Broekhuizen; J Godoy; S Mondaca; A Catenaccio; P Macanas; B Nervi; M Calvo; F A Court
Journal:  Neurobiol Pain       Date:  2020-05-22

Review 3.  Lost in Translation? Measuring Diabetic Neuropathy in Humans and Animals.

Authors:  Heung Yong Jin; Seong-Su Moon; Nigel A Calcutt
Journal:  Diabetes Metab J       Date:  2020-12-15       Impact factor: 5.376

4.  Acidic fibroblast growth factor attenuates type 2 diabetes-induced demyelination via suppressing oxidative stress damage.

Authors:  Rui Li; Beini Wang; Chengbiao Wu; Duohui Li; Yanqing Wu; Libing Ye; Luxia Ye; Xiongjian Chen; Peifeng Li; Yuan Yuan; Hongyu Zhang; Ling Xie; Xiaokun Li; Jian Xiao; Jian Wang
Journal:  Cell Death Dis       Date:  2021-01-21       Impact factor: 8.469

5.  Corneal confocal microscopy compared with quantitative sensory testing and nerve conduction for diagnosing and stratifying the severity of diabetic peripheral neuropathy.

Authors:  Maryam Ferdousi; Alise Kalteniece; Shazli Azmi; Ioannis N Petropoulos; Anne Worthington; Luca D'Onofrio; Shaishav Dhage; Georgios Ponirakis; Uazman Alam; Andrew Marshall; Catharina G Faber; Giuseppe Lauria; Handrean Soran; Rayaz A Malik
Journal:  BMJ Open Diabetes Res Care       Date:  2020-12

Review 6.  Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy.

Authors:  Wei Zheng So; Natalie Shi Qi Wong; Hong Chang Tan; Molly Tzu Yu Lin; Isabelle Xin Yu Lee; Jodhbir S Mehta; Yu-Chi Liu
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

7.  Current concepts for the evaluation and management of diabetic foot ulcers.

Authors:  Andreas F Mavrogenis; Panayiotis D Megaloikonomos; Thekla Antoniadou; Vasilios G Igoumenou; Georgios N Panagopoulos; Leonidas Dimopoulos; Konstantinos G Moulakakis; George S Sfyroeras; Andreas Lazaris
Journal:  EFORT Open Rev       Date:  2018-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.